First independent assessment of pharmaceutical company action on AMR. Pharmaceutical companies have a long way to go to combat antimicrobial resistance, but a new ranking aims to hold them accountable. The Benchmark found that nine of the 19 companies reporting such efforts are running or supporting 19 AMR surveillance programmes across 147 countries.
antimicrobial, Antimicrobial resistance,
